Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.

OBJECTIVE A previous positron emission tomography (PET) study reported increased serotonin 5-HT(2A) receptor binding in unmedicated depressed patients with high scores on the Dysfunctional Attitudes Scale. The purpose of the present study was to use the highly selective 5-HT(2A) receptor ligand [(11)C]MDL 100,907 in a PET imaging paradigm to assess 1) 5-HT(2A) receptor binding potential in euthymic subjects with a history of recurrent depression and 2) the relationship between receptor binding and scores on the Dysfunctional Attitudes Scale. METHOD Cortical 5-HT(2A) receptor binding was measured in 20 unmedicated, fully recovered unipolar depressed patients and 20 age- and gender-matched comparison subjects. Regional estimates of binding potential were obtained using a reversible plasma input function compartmental model and the cerebellum as a reference region to estimate the free and non-specifically bound [(11)C]MDL 100,907 in brain tissue. RESULTS Relative to the comparison subjects, the recovered depressed patients demonstrated significantly higher 5-HT(2A) receptor binding potential in the frontal cortex (mean increase: 19%), parietal cortex (mean increase: 25%), and occipital cortex (mean increase: 19%). 5-HT(2A) receptor binding potential correlated negatively with age in both patients and comparison subjects and positively with the Dysfunctional Attitudes Scale in the recovered patients. CONCLUSIONS These findings should be considered preliminary but suggest that recovered subjects with a history of recurrent major depression have elevated binding potential of cortical 5-HT(2A) receptors. The correlation of increased 5-HT(2A) receptor binding potential with increased scores on Dysfunctional Attitudes Scale supports earlier work suggesting that increased 5-HT(2A) receptor availability characterizes a group of depressed patients with high levels of dysfunctional attitudes.

[1]  T. Spinks,et al.  Physical characteristics of the ECAT EXACT3D positron tomograph. , 2000, Physics in medicine and biology.

[2]  V. Arango,et al.  Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. , 1990, Archives of general psychiatry.

[3]  P. McGuffin,et al.  The Dysfunctional Attitude Scale (DAS): A comparison of forms A and B and proposals for a new subscaled version , 1994 .

[4]  Susan Hume,et al.  Fenfluramine evokes 5‐HT2A receptor‐mediated responses but does not displace [11C]MDL 100907: Small animal PET and gene expression studies , 2003, Synapse.

[5]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[6]  D J Kupfer,et al.  Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. , 1991, Archives of general psychiatry.

[7]  P. Cowen,et al.  State and trait abnormalities in serotonin function in major depression. , 2002, The British journal of psychiatry : the journal of mental science.

[8]  W C Eckelman,et al.  Kinetic Analysis of the 5-HT2A Ligand [11C]MDL 100,907 , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  A. Deutch,et al.  Serotonin 5‐HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex , 1997, Synapse.

[10]  J. Kleinman,et al.  Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. , 1993, Archives of general psychiatry.

[11]  Sylvain Houle,et al.  Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. , 2003, The American journal of psychiatry.

[12]  C. Stockmeier.  Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. , 2003, Journal of psychiatric research.

[13]  C. Halldin,et al.  PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  M. Alda,et al.  Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. , 1999, The American journal of psychiatry.

[15]  P A Sargent,et al.  Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635 , 2004, Molecular Psychiatry.

[16]  Andrei G. Vlassenko,et al.  Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography , 2004, Biological Psychiatry.

[17]  S. Maier,et al.  Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus , 2005, Nature Neuroscience.

[18]  C. Halldin,et al.  [11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography. , 1996, Life sciences.

[19]  R A Robb,et al.  Analyze: a comprehensive, operator-interactive software package for multidimensional medical image display and analysis. , 1989, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[20]  Paul J. Harrison,et al.  The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain , 1995, Brain Research.

[21]  Vincent J Cunningham,et al.  Validation of a Tracer Kinetic Model for the Quantification of 5-HT2A Receptors in Human Brain with [11C]MDL 100,907 , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  David A Lewis,et al.  The Human Brain Revisited: Opportunities and Challenges in Postmortem Studies of Psychiatric Disorders , 2002, Neuropsychopharmacology.

[23]  John A. Nelder,et al.  A Simplex Method for Function Minimization , 1965, Comput. J..

[24]  Sylvain Houle,et al.  Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. , 2004, Archives of general psychiatry.

[25]  J. Marcusson,et al.  Brain 5-HT1A, 5-HT1D, and 5-HT2 Receptors in suicide victims , 1994, Biological Psychiatry.

[26]  S. Kapur,et al.  Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. , 1999, The American journal of psychiatry.

[27]  D. Zuroff,et al.  Vulnerability to depression: reexamining state dependence and relative stability. , 1999, Journal of abnormal psychology.

[28]  M. Palkovits,et al.  5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala , 1993, Brain Research.

[29]  Z. Segal,et al.  Mood-induced changes on the Implicit Association Test in recovered depressed patients. , 2001, Journal of abnormal psychology.

[30]  Jacob Cohen.  Statistical Power Analysis , 1992 .

[31]  Bryan L Roth,et al.  The interaction of a constitutively active arrestin with the arrestin-insensitive 5-HT(2A) receptor induces agonist-independent internalization. , 2003, Molecular pharmacology.

[32]  P. Celada,et al.  In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents. , 2003, Cerebral cortex.

[33]  P M Bloomfield,et al.  The on-line monitoring of continuously withdrawn arterial blood during PET studies using a single BGO/photomultiplier assembly and non-stick tubing. , 1991, Medical progress through technology.

[34]  W C Eckelman,et al.  Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous Infusion , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  P B Hoffer,et al.  Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  A. Farmer,et al.  The Cardiff Depression Study: a sib-pair study of dysfunctional attitudes in depressed probands and healthy control subjects , 2001, Psychological Medicine.

[37]  D. Charney,et al.  Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent. , 1999, Nuclear medicine and biology.

[38]  G. Sedvall,et al.  Autoradiographic localization of 5‐HT2A receptors in the human brain using [3H]M100907 and [11C]M100907 , 2000, Synapse.

[39]  P. Goldman-Rakic,et al.  Segregation of serotonin 5‐HT2A and 5‐HT3 receptors in inhibitory circuits of the primate cerebral cortex , 2000, The Journal of comparative neurology.

[40]  A. Biegon,et al.  Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. , 1989, Archives of general psychiatry.